World Health Organization Advised to Swap Surgical Face Masks with Respirator-Level Masks Amid Calls for Better Protection Against Flu-Like Illnesses
The World Health Organization (WHO) is being urged to update its guidelines to recommend respirator-level masks instead of surgical face masks, citing inadequate protection against flu-like illnesses such as COVID-19. Experts argue that the widely used surgical masks are no longer sufficient and should be phased out in favor of more effective respirators.
The call for change comes as a group of seven clinicians and scientists, including University of Michigan School of Public Health professor Adam Finkel, wrote to WHO chief Dr Tedros Adhanom Ghebreyesus, urging the organization to adopt new guidelines that prioritize respirator-level masks. The letter argues that there is "no rational justification remaining" for using surgical masks in healthcare settings and that they provide inadequate protection against airborne pathogens.
The proposal would require hospitals and clinics to switch from surgical face masks to respirators, such as FFP2/3 standards in the UK or N95 in the US, during medical interactions. Proponents argue that this change could significantly reduce infections among patients and healthcare workers, as well as rates of sickness, absence, and burnout.
Finkel, who was chief regulatory official at the US Occupational Safety and Health Administration between 1995 and 2000, likens surgical masks to "obsolete" technology compared to respirators. He notes that while surgical masks are better than nothing, they offer only about 40% protection against COVID-19 particles, whereas respirators can block up to 98%.
Critics of the group's arguments point out that there is currently a lack of randomized controlled trials demonstrating the effectiveness of physical measures in slowing the spread of respiratory viruses. However, Finkel and other authors argue that laboratory tests showing the efficacy of respirators provide sufficient evidence.
The WHO has been criticized for its initial response to COVID-19, with some arguing that it was slow to describe the virus as spreading via airborne particles. The letter also calls for the organization to revisit earlier statements and inform the public unequivocally that COVID-19 spreads through airborne respiratory particles.
As the pandemic continues, experts are urging a more effective approach to protecting healthcare workers and patients from flu-like illnesses. With the WHO's guidance on personal protective equipment for health workers under review, this call for change may yet have a significant impact on global public health efforts.
The World Health Organization (WHO) is being urged to update its guidelines to recommend respirator-level masks instead of surgical face masks, citing inadequate protection against flu-like illnesses such as COVID-19. Experts argue that the widely used surgical masks are no longer sufficient and should be phased out in favor of more effective respirators.
The call for change comes as a group of seven clinicians and scientists, including University of Michigan School of Public Health professor Adam Finkel, wrote to WHO chief Dr Tedros Adhanom Ghebreyesus, urging the organization to adopt new guidelines that prioritize respirator-level masks. The letter argues that there is "no rational justification remaining" for using surgical masks in healthcare settings and that they provide inadequate protection against airborne pathogens.
The proposal would require hospitals and clinics to switch from surgical face masks to respirators, such as FFP2/3 standards in the UK or N95 in the US, during medical interactions. Proponents argue that this change could significantly reduce infections among patients and healthcare workers, as well as rates of sickness, absence, and burnout.
Finkel, who was chief regulatory official at the US Occupational Safety and Health Administration between 1995 and 2000, likens surgical masks to "obsolete" technology compared to respirators. He notes that while surgical masks are better than nothing, they offer only about 40% protection against COVID-19 particles, whereas respirators can block up to 98%.
Critics of the group's arguments point out that there is currently a lack of randomized controlled trials demonstrating the effectiveness of physical measures in slowing the spread of respiratory viruses. However, Finkel and other authors argue that laboratory tests showing the efficacy of respirators provide sufficient evidence.
The WHO has been criticized for its initial response to COVID-19, with some arguing that it was slow to describe the virus as spreading via airborne particles. The letter also calls for the organization to revisit earlier statements and inform the public unequivocally that COVID-19 spreads through airborne respiratory particles.
As the pandemic continues, experts are urging a more effective approach to protecting healthcare workers and patients from flu-like illnesses. With the WHO's guidance on personal protective equipment for health workers under review, this call for change may yet have a significant impact on global public health efforts.